Big Tech, Big Pay: Evaluating Executive Compensation

Big Tech, Big Pay: Evaluating Executive Compensation

What tech executives are rewarded for may matter more than how much they’re paid.

Eye-popping pay packages have made executive compensation a perennial Big Tech flashpoint. Yet headline pay figures often tell investors little about the quality of a company’s incentive structure. By contrast, compensation design can offer insight into accountability, innovation discipline and long-term shareholder outcomes—for technology companies of any size. We believe three dimensions of executive compensation can serve as a useful investment lens.

Evidence That Compensation Design Matters

Tech CEOs receive some of the largest compensation packages in the market. Median total compensation for US tech CEOs reached $22.5 million in the 2026 proxy season, second only to communication services. But the size of an award reveals little about whether it serves shareholders well.

A large package may be justified if it rewards exceptional value creation without encouraging excessive risk or short-term decisions. A smaller package can still be poorly designed if executives receive substantial rewards despite weak shareholder outcomes.

For investors, the more useful analysis begins with how compensation is structured, what performance it rewards and how long executives must remain exposed to the consequences of their decisions. Our analysis suggests that these distinctions may carry investment information.

We examined the subsequent performance of Russell 1000 technology companies based on our proprietary say-on-pay assessment. Since 2018, companies whose compensation programs we supported have generated stronger returns and better risk-reward characteristics than those whose programs we opposed (Display).

AB-Supported Compensation Programs Delivered Stronger Outcomes

Compensation design alone cannot predict stock returns. But the relationship suggests that a well-constructed pay program may reflect broader attributes of corporate quality, including disciplined target setting, accountability and a willingness to invest for the future.

See more: Three Forces Carrying Biotech into 2027